| scholarly article | Q13442814 |
| P50 | author | Simon W. Jones | Q55486175 |
| P2093 | author name string | Mark A Lindsay | |
| Sarah M V Brockbank | |||
| Peter Newham | |||
| Catherine J Voyce | |||
| Ken Bundell | |||
| Richard Christison | |||
| P2860 | cites work | HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses | Q24564896 |
| Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide | Q24796110 | ||
| Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans | Q28140638 | ||
| Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides | Q28144903 | ||
| Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex | Q28145172 | ||
| Integral membrane heparan sulfate proteoglycans | Q28262453 | ||
| In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis | Q28570309 | ||
| Clathrin-coated vesicle formation and protein sorting: an integrated process | Q29619729 | ||
| Cellular uptake of the tat protein from human immunodeficiency virus | Q29620627 | ||
| Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells | Q30728924 | ||
| Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice | Q31115814 | ||
| Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice | Q31137383 | ||
| Cell-penetrating peptides. | Q33846582 | ||
| Protection against ischemic brain injury by protein therapeutics | Q34431022 | ||
| Protein transduction technology | Q34534961 | ||
| Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein | Q34556566 | ||
| Peptide-mediated cell delivery: application in protein target validation | Q34905149 | ||
| Protein transduction domains: are they delivering? | Q35136309 | ||
| Rapid cycling of lipid raft markers between the cell surface and Golgi complex | Q36360365 | ||
| Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT | Q36371501 | ||
| Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery | Q39643032 | ||
| Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. | Q40591045 | ||
| Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction | Q40629590 | ||
| Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins | Q40644120 | ||
| Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake | Q40692947 | ||
| Possible existence of common internalization mechanisms among arginine-rich peptides | Q40768223 | ||
| Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat. | Q40812571 | ||
| The proteoglycan perlecan is expressed in the erythroleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester | Q41350705 | ||
| Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. | Q42632235 | ||
| Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. | Q43440370 | ||
| Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. | Q43726340 | ||
| Blockade of airway inflammation and hyperresponsiveness by HIV-TAT-dominant negative Ras. | Q43793119 | ||
| Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells | Q43812561 | ||
| The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists | Q43822559 | ||
| Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions | Q44193907 | ||
| Protection of islets by in situ peptide-mediated transduction of the Ikappa B kinase inhibitor Nemo-binding domain peptide. | Q44276037 | ||
| Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time | Q44541953 | ||
| A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia | Q44560865 | ||
| Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo | Q47446256 | ||
| Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. | Q47448961 | ||
| Cellular translocation of proteins by transportan | Q59662721 | ||
| In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation | Q60695434 | ||
| A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus | Q63343005 | ||
| Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10. Inhibition of cAMP-dependent protein kinase | Q69679823 | ||
| Transduction of Cu,Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into mammalian cells | Q73230902 | ||
| [Protein transduction by poly-arginine] | Q73594692 | ||
| Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice | Q73738455 | ||
| Inhibition of pRb phosphorylation and cell cycle progression by an antennapedia-p16(INK4A) fusion peptide in pancreatic cancer cells | Q74342337 | ||
| Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice | Q77924606 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1093-1102 | |
| P577 | publication date | 2005-08-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Characterisation of cell-penetrating peptide-mediated peptide delivery | |
| P478 | volume | 145 |
| Q57369907 | A Novel Cell-penetrating Peptide, M918, for Efficient Delivery of Proteins and Peptide Nucleic Acids |
| Q34568075 | A cell-permeable gadolinium contrast agent for magnetic resonance imaging of copper in a Menkes disease model |
| Q37034573 | A common landscape for membrane-active peptides |
| Q60934489 | A new role of anterograde motor Kif5b in facilitating large clathrin-coated vesicle mediated endocytosis via regulating clathrin uncoating |
| Q38703800 | A novel nanoemulsion-based method to produce ultrasmall, water-dispersible nanoparticles from chitosan, surface modified with cell-penetrating peptide for oral delivery of proteins and peptides |
| Q28538467 | A phase I clinical trial of systemically delivered NEMO binding domain peptide in dogs with spontaneous activated B-cell like diffuse large B-cell lymphoma |
| Q24319007 | A short Nur77-derived peptide converts Bcl-2 from a protector to a killer |
| Q41940806 | Adenosine-oligoarginine conjugate, a novel bisubstrate inhibitor, effectively dissociates the actin cytoskeleton |
| Q38973145 | Amphiphilic bicyclic peptides as cellular delivery agents |
| Q34725033 | Analysis of protein kinase A activity in insulin-secreting cells using a cell-penetrating protein substrate and capillary electrophoresis |
| Q51317921 | Antiangiogenic Therapeutic Potential of Peptides Derived from the Molecular Motor KIF13B that Transports VEGFR2 to Plasmalemma in Endothelial Cells. |
| Q37635334 | Arginine-rich cell-penetrating peptides. |
| Q27318674 | Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA. |
| Q54315740 | Bifidobacterium longum modified recombinant HU protein as a vector for nonviral delivery of DNA to HEK293 human cell culture. |
| Q33782756 | Bridged beta(3)-peptide inhibitors of p53-hDM2 complexation: correlation between affinity and cell permeability |
| Q39581513 | Calcium condensation of DNA complexed with cell-penetrating peptides offers efficient, noncytotoxic gene delivery |
| Q39252765 | Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study |
| Q39955713 | Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling |
| Q39629419 | Cell line-dependent internalization pathways determine DNA transfection efficiency of decaarginine-PEG-lipid |
| Q34289086 | Cell penetrating peptide inhibitors of nuclear factor-kappa B. |
| Q39627637 | Cell permeable ITAM constructs for the modulation of mediator release in mast cells. |
| Q34606888 | Cell-Penetrating Penta-Peptides (CPP5s): Measurement of Cell Entry and Protein-Transduction Activity |
| Q36897400 | Cell-penetrating TIR BB loop decoy peptides a novel class of TLR signaling inhibitors and a tool to study topology of TIR-TIR interactions |
| Q41208099 | Cell-penetrating antimicrobial peptides - prospectives for targeting intracellular infections |
| Q39473535 | Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters |
| Q41077384 | Cell-penetrating peptide-mediated subunit vaccine generates a potent immune response and protection against Streptococcus iniae in Japanese flounder (Paralichthys olivaceus). |
| Q26801860 | Cell-penetrating peptides and their analogues as novel nanocarriers for drug delivery |
| Q37039034 | Cell-penetrating peptides for drug delivery across membrane barriers |
| Q34373522 | Cell-permeable beta-peptide inhibitors of p53/hDM2 complexation |
| Q41942565 | Cellular internalization of green fluorescent protein fused with herpes simplex virus protein VP22 via a lipid raft-mediated endocytic pathway independent of caveolae and Rho family GTPases but dependent on dynamin and Arf6. |
| Q33742595 | Cellular uptake of ribonuclease A relies on anionic glycans |
| Q43898698 | Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy |
| Q34504889 | Characterization of a novel cell penetrating peptide derived from human Oct4. |
| Q28535219 | Chemical-functional diversity in cell-penetrating peptides |
| Q38683252 | Classification and function of small open reading frames. |
| Q61797303 | Combination of Cell-Penetrating Peptides with Nanoparticles for Therapeutic Application: A Review |
| Q92933026 | Comparative Molecular Transporter Efficiency of Cyclic Peptides Containing Tryptophan and Arginine Residues |
| Q36510057 | Comparative study on transduction and toxicity of protein transduction domains. |
| Q38870536 | Conjugation of photosensitisers to antimicrobial peptides increases the efficiency of photodynamic therapy in cancer cells. |
| Q35545342 | Conscripts of the infinite armada: systemic cancer therapy using nanomaterials. |
| Q24644495 | Defensins and the convergent evolution of platypus and reptile venom genes |
| Q36583833 | Development of viral nanoparticles for efficient intracellular delivery. |
| Q40037002 | Digital switching of local arginine density in a genetically encoded self-assembled polypeptide nanoparticle controls cellular uptake. |
| Q35461043 | Direct protein delivery to mammalian cells using cell-permeable Cys2-His2 zinc-finger domains |
| Q48209105 | Disrupted-in-schizophrenia 1 regulates transport of ITPR1 mRNA for synaptic plasticity |
| Q83357754 | Dynamics of transportan in bicelles is surface charge dependent |
| Q35609988 | Efficient Cargo Delivery into Adult Brain Tissue Using Short Cell-Penetrating Peptides |
| Q41962793 | Efficient Intracellular Delivery of a Pro-Apoptotic Peptide With A pH-Responsive Carrier |
| Q37328068 | Efficient siRNA delivery with non-viral polymeric vehicles |
| Q48021428 | Enantiomeric and diastereoisomeric (mixed) L/ D-octaarginine derivatives - a simple way of modulating the properties of cell-penetrating peptides |
| Q40199589 | Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide. |
| Q37043911 | Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides |
| Q58564633 | Fluorescence Correlation Spectroscopy Reveals Efficient Cytosolic Delivery of Protein Cargo by Cell-Permeant Miniature Proteins |
| Q36175053 | HIV-1 Tat membrane interactions probed using X-ray and neutron scattering, CD spectroscopy and MD simulations |
| Q59354526 | Highly efficient cellular uptake of a cell-penetrating peptide (CPP) derived from the capsid protein of porcine circovirus type 2 |
| Q33285497 | How to address CPP and AMP translocation? Methods to detect and quantify peptide internalization in vitro and in vivo (Review). |
| Q33581909 | Imaging the DNA damage response with PET and SPECT |
| Q37277330 | Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges |
| Q48867737 | Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier |
| Q39828424 | Inhibition of intracellular growth of Salmonella enterica serovar Typhimurium in tissue culture by antisense peptide-phosphorodiamidate morpholino oligomer |
| Q39382518 | Insights into the uptake mechanism of NrTP, a cell-penetrating peptide preferentially targeting the nucleolus of tumour cells |
| Q92900087 | Internalization mechanisms of cell-penetrating peptides |
| Q39039132 | Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells |
| Q37641466 | Intracellular delivery of cell-penetrating peptide-transcriptional factor fusion protein and its role in selective osteogenesis |
| Q37176400 | Intracellular delivery of nanoparticles via the HIV-1 tat peptide |
| Q37995239 | Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application |
| Q45868411 | Intranuclear protein transduction through a nucleoside salvage pathway |
| Q33580471 | LXXLL peptide converts transportan 10 to a potent inducer of apoptosis in breast cancer cells |
| Q37052581 | Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. |
| Q37712074 | Macrocyclized Extended Peptides: Inhibiting the Substrate-Recognition Domain of Tankyrase. |
| Q35997331 | Monitoring the cytosolic entry of cell-penetrating peptides using a pH-sensitive fluorophore |
| Q55020290 | NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death. |
| Q57570763 | Nanoparticle Functionalization for Brain Targeting Drug Delivery and Diagnostic |
| Q39255968 | Nanoscale Biodegradable Organic-Inorganic Hybrids for Efficient Cell Penetration and Drug Delivery |
| Q36098382 | Novel Regulator of Acylated Ghrelin, CF801, Reduces Weight Gain, Rebound Feeding after a Fast, and Adiposity in Mice |
| Q34655246 | One single method to produce native and Tat-fused recombinant human α-synuclein in Escherichia coli. |
| Q37572760 | Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics. |
| Q37115553 | Peptide-functionalized poly(ethylene glycol) star polymers: DNA delivery vehicles with multivalent molecular architecture |
| Q38285852 | Peptide-mediated delivery: an overview of pathways for efficient internalization |
| Q39808371 | Peptides that mimic the amino-terminal end of the rabies virus phosphoprotein have antiviral activity |
| Q92146043 | Pharmacological inhibition of Bax-induced cell death: Bax-inhibiting peptides and small compounds inhibiting Bax |
| Q36004826 | Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing |
| Q36237331 | Precision targeted ruthenium(ii) luminophores; highly effective probes for cell imaging by stimulated emission depletion (STED) microscopy |
| Q35900519 | Protein delivery using Cys2-His2 zinc-finger domains |
| Q33938342 | Screening of a combinatorial homing peptide library for selective cellular delivery |
| Q39444425 | Screening of cell-penetrating peptides using mRNA display |
| Q96816639 | Selection and identification of a novel bone-targeting peptide for biomedical imaging of bone |
| Q39405544 | Solid-phase synthesis of oxaliplatin-TAT peptide bioconjugates. |
| Q41481601 | Spider Toxin Peptide Lycosin-I Functionalized Gold Nanoparticles for in vivo Tumor Targeting and Therapy |
| Q33769108 | Structure analysis and conformational transitions of the cell penetrating peptide transportan 10 in the membrane-bound state |
| Q38819546 | Surface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug delivery. |
| Q34977314 | Synthesis and effects of conjugated tocopherol analogues on peptide nucleic acid hybridisation. |
| Q83417203 | Synthesis of N-methylated cyclic peptides |
| Q59103173 | Synthetic Crossfeeding Cocultures in Yeast: Computational Model of Autoregulation and Design of a Tryptophan Export Device |
| Q37731951 | Targeting TLR/IL-1R signalling in human diseases. |
| Q34054988 | Tat-Mediated Peptide Intervention in Analgesia and Anesthesia. |
| Q50970899 | Tat-tetanus toxin fragment C: a novel protein delivery vector and its use with photochemical internalization. |
| Q51949042 | The 11-aminoacid long Tarsal-less peptides trigger a cell signal in Drosophila leg development. |
| Q24313366 | The IkappaB kinase complex: master regulator of NF-kappaB signaling |
| Q40031669 | The N-terminal domain of y-box binding protein-1 induces cell cycle arrest in g2/m phase by binding to cyclin d1 |
| Q37047226 | The design of guanidinium-rich transporters and their internalization mechanisms. |
| Q36695464 | The taming of the cell penetrating domain of the HIV Tat: myths and realities |
| Q38104407 | Therapeutic potential of cell-penetrating peptides. |
| Q43842753 | Thermodynamics of Lipid Interactions with Cell-Penetrating Peptides |
| Q37141630 | Towards the development of an enzyme replacement therapy for the metabolic disorder propionic acidemia |
| Q83939141 | Use of a penetratin-linked peptide in Dictyostelium |
| Q42827488 | Use of vivo-morpholinos for control of protein expression in the adult rat brain |
| Q46783979 | Vesicular disruption of lysosomal targeting organometallic polyarginine bioconjugates |
Search more.